ID   ENPP7_RAT               Reviewed;         439 AA.
AC   Q5EZ72;
DT   07-JUN-2005, integrated into UniProtKB/Swiss-Prot.
DT   15-MAR-2005, sequence version 1.
DT   29-MAY-2024, entry version 93.
DE   RecName: Full=Ectonucleotide pyrophosphatase/phosphodiesterase family member 7 {ECO:0000305};
DE            Short=E-NPP 7;
DE            Short=NPP-7;
DE            EC=3.1.4.12 {ECO:0000269|PubMed:15708357, ECO:0000269|PubMed:16255717};
DE   AltName: Full=Alkaline sphingomyelin phosphodiesterase;
DE   AltName: Full=Intestinal alkaline sphingomyelinase {ECO:0000303|PubMed:15205117, ECO:0000303|PubMed:15708357};
DE            Short=Alk-SMase {ECO:0000250|UniProtKB:Q6UWV6};
DE   Flags: Precursor;
GN   Name=Enpp7 {ECO:0000312|RGD:1359324};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 32-40; 106-116; 204-211;
RP   221-226; 255-263 AND 317-342, IDENTIFICATION BY MASS SPECTROMETRY,
RP   CATALYTIC ACTIVITY, FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES, AND TISSUE
RP   SPECIFICITY.
RC   STRAIN=Sprague-Dawley; TISSUE=Intestinal mucosa;
RX   PubMed=15708357; DOI=10.1016/j.bbalip.2004.11.006;
RA   Wu J., Cheng Y., Palmberg C., Bergman T., Nilsson A., Duan R.-D.;
RT   "Cloning of alkaline sphingomyelinase from rat intestinal mucosa and
RT   adjusting of the hypothetical protein XP_221184 in GenBank.";
RL   Biochim. Biophys. Acta 1687:94-102(2005).
RN   [2]
RP   SUBCELLULAR LOCATION, TOPOLOGY, AND TISSUE SPECIFICITY.
RX   PubMed=15205117; DOI=10.1152/ajpgi.00190.2004;
RA   Wu J., Liu F., Nilsson A., Duan R.D.;
RT   "Pancreatic trypsin cleaves intestinal alkaline sphingomyelinase from
RT   mucosa and enhances the sphingomyelinase activity.";
RL   Am. J. Physiol. 287:G967-G973(2004).
RN   [3]
RP   CATALYTIC ACTIVITY, FUNCTION, ACTIVITY REGULATION, BIOPHYSICOCHEMICAL
RP   PROPERTIES, AND MUTAGENESIS OF ASP-198 AND ASP-245.
RX   PubMed=16255717; DOI=10.1042/bj20051121;
RA   Wu J., Nilsson A., Joensson B.A., Stenstad H., Agace W., Cheng Y.,
RA   Duan R.D.;
RT   "Intestinal alkaline sphingomyelinase hydrolyses and inactivates platelet-
RT   activating factor by a phospholipase C activity.";
RL   Biochem. J. 394:299-308(2006).
CC   -!- FUNCTION: Choline-specific phosphodiesterase that hydrolyzes
CC       sphingomyelin (SM) releasing the ceramide and phosphocholine and
CC       therefore is involved in sphingomyelin digestion, ceramide formation,
CC       and fatty acid (FA) absorption in the gastrointestinal tract
CC       (PubMed:15708357, PubMed:16255717). Has also phospholipase C activity
CC       and can also cleave phosphocholine from palmitoyl lyso-
CC       phosphatidylcholine and platelet-activating factor (PAF) leading to its
CC       inactivation. Does not have nucleotide pyrophosphatase activity
CC       (PubMed:16255717). May promote cholesterol absorption by affecting the
CC       levels of sphingomyelin derived from either diet or endogenous sources,
CC       in the intestinal lumen (By similarity). {ECO:0000250|UniProtKB:Q3TIW9,
CC       ECO:0000269|PubMed:15708357, ECO:0000269|PubMed:16255717}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a sphingomyelin + H2O = an N-acylsphing-4-enine + H(+) +
CC         phosphocholine; Xref=Rhea:RHEA:19253, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:17636, ChEBI:CHEBI:52639,
CC         ChEBI:CHEBI:295975; EC=3.1.4.12;
CC         Evidence={ECO:0000269|PubMed:15708357, ECO:0000269|PubMed:16255717};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:19254;
CC         Evidence={ECO:0000305|PubMed:15708357};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine + H2O = a 1-
CC         O-alkyl-2-acetyl-sn-glycerol + H(+) + phosphocholine;
CC         Xref=Rhea:RHEA:63380, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:16291, ChEBI:CHEBI:36707, ChEBI:CHEBI:295975;
CC         Evidence={ECO:0000269|PubMed:16255717};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:63381;
CC         Evidence={ECO:0000305|PubMed:16255717};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-O-octadecyl-2-acetyl-sn-glycero-3-phosphocholine + H2O = 1-
CC         O-octadecyl-2-acetyl-sn-glycerol + H(+) + phosphocholine;
CC         Xref=Rhea:RHEA:63384, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:52450, ChEBI:CHEBI:147296, ChEBI:CHEBI:295975;
CC         Evidence={ECO:0000269|PubMed:16255717};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:63385;
CC         Evidence={ECO:0000305|PubMed:16255717};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-sn-glycero-3-phosphocholine + H2O = 1-
CC         hexadecanoyl-sn-glycerol + H(+) + phosphocholine;
CC         Xref=Rhea:RHEA:41119, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:72998, ChEBI:CHEBI:75542, ChEBI:CHEBI:295975;
CC         Evidence={ECO:0000250|UniProtKB:Q6UWV6};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41120;
CC         Evidence={ECO:0000250|UniProtKB:Q6UWV6};
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000250|UniProtKB:Q6UWV6};
CC   -!- ACTIVITY REGULATION: platelet-activating factor hydrolysis is inhibited
CC       by higher amount of sphingomyelin (PubMed:16255717). The hydrolysis of
CC       platelet-activating factor and sphingomyelin can be inhibited by the
CC       presence of sphingomyelin and platelet-activating factor respectively,
CC       the inhibition of platelet-activating factor hydrolysis by
CC       sphingomyelin being stronger (PubMed:16255717). PAF hydrolysis is dose-
CC       dependently increased by both taurocholate (TC) and taurodeoxycholate
CC       (TDC) (PubMed:16255717). Hydrolase activity against PAF is inhibited by
CC       EDTA and stimulated by 0.1-0.25 mM Zn2+ (PubMed:16255717).
CC       {ECO:0000269|PubMed:16255717}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=13.6 uM for 2-acetyl-1-alkyl-sn-glycero-3-phosphocholine
CC         {ECO:0000269|PubMed:16255717};
CC         Vmax=374 umol/h/mg enzyme {ECO:0000269|PubMed:16255717};
CC       pH dependence:
CC         Optimum pH is 7.5 (PubMed:16255717). Optimum pH is 9
CC         (PubMed:15708357). {ECO:0000269|PubMed:15708357,
CC         ECO:0000269|PubMed:16255717};
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:15205117};
CC       Single-pass type I membrane protein {ECO:0000269|PubMed:15205117}.
CC       Note=The catalytic domain is released into the extracellular medium
CC       when cells are treated with trypsin (PubMed:15205117). Localized at the
CC       surface of the microvillar membrane in small intestine enterocytes, and
CC       in endosome-like structures situated beneath the microvillar membrane,
CC       and in Golgi complex (By similarity). {ECO:0000250|UniProtKB:Q6UWV6,
CC       ECO:0000269|PubMed:15205117}.
CC   -!- TISSUE SPECIFICITY: Detected in small intestine (at protein level)
CC       (PubMed:15205117). Highly expressed in the jejunum (PubMed:15708357).
CC       {ECO:0000269|PubMed:15205117, ECO:0000269|PubMed:15708357}.
CC   -!- PTM: N-glycosylated; required for activity and transport to the plasma
CC       membrane. {ECO:0000250|UniProtKB:Q6UWV6}.
CC   -!- SIMILARITY: Belongs to the nucleotide pyrophosphatase/phosphodiesterase
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY568760; AAU03450.1; -; mRNA.
DR   RefSeq; NP_001012484.1; NM_001012466.1.
DR   AlphaFoldDB; Q5EZ72; -.
DR   SMR; Q5EZ72; -.
DR   STRING; 10116.ENSRNOP00000064040; -.
DR   GlyCosmos; Q5EZ72; 5 sites, No reported glycans.
DR   GlyGen; Q5EZ72; 5 sites.
DR   PhosphoSitePlus; Q5EZ72; -.
DR   PaxDb; 10116-ENSRNOP00000064040; -.
DR   GeneID; 303729; -.
DR   KEGG; rno:303729; -.
DR   AGR; RGD:1359324; -.
DR   CTD; 339221; -.
DR   RGD; 1359324; Enpp7.
DR   eggNOG; KOG2645; Eukaryota.
DR   InParanoid; Q5EZ72; -.
DR   OrthoDB; 1366859at2759; -.
DR   PhylomeDB; Q5EZ72; -.
DR   Reactome; R-RNO-9840310; Glycosphingolipid catabolism.
DR   PRO; PR:Q5EZ72; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005794; C:Golgi apparatus; ISO:RGD.
DR   GO; GO:0005902; C:microvillus; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0008081; F:phosphoric diester hydrolase activity; IDA:UniProtKB.
DR   GO; GO:0004767; F:sphingomyelin phosphodiesterase activity; IDA:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; ISS:UniProtKB.
DR   GO; GO:0055089; P:fatty acid homeostasis; ISS:UniProtKB.
DR   GO; GO:0044241; P:lipid digestion; ISS:UniProtKB.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:0008156; P:negative regulation of DNA replication; ISO:RGD.
DR   GO; GO:2000304; P:positive regulation of ceramide biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0045797; P:positive regulation of intestinal cholesterol absorption; ISS:UniProtKB.
DR   GO; GO:2000755; P:positive regulation of sphingomyelin catabolic process; ISS:UniProtKB.
DR   GO; GO:1904729; P:regulation of intestinal lipid absorption; ISS:UniProtKB.
DR   GO; GO:0006684; P:sphingomyelin metabolic process; ISS:UniProtKB.
DR   CDD; cd16018; Enpp; 1.
DR   Gene3D; 3.30.1360.180; -; 1.
DR   Gene3D; 3.40.720.10; Alkaline Phosphatase, subunit A; 1.
DR   InterPro; IPR017850; Alkaline_phosphatase_core_sf.
DR   InterPro; IPR002591; Phosphodiest/P_Trfase.
DR   PANTHER; PTHR10151; ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE; 1.
DR   PANTHER; PTHR10151:SF63; ECTONUCLEOTIDE PYROPHOSPHATASE_PHOSPHODIESTERASE FAMILY MEMBER 7; 1.
DR   Pfam; PF01663; Phosphodiest; 1.
DR   SUPFAM; SSF53649; Alkaline phosphatase-like; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Direct protein sequencing; Glycoprotein; Hydrolase;
KW   Lipid metabolism; Membrane; Metal-binding; Reference proteome; Signal;
KW   Transmembrane; Transmembrane helix; Zinc.
FT   SIGNAL          1..21
FT                   /evidence="ECO:0000255"
FT   CHAIN           22..439
FT                   /note="Ectonucleotide pyrophosphatase/phosphodiesterase
FT                   family member 7"
FT                   /id="PRO_0000036404"
FT   TOPO_DOM        22..422
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305|PubMed:15205117"
FT   TRANSMEM        423..439
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   REGION          71..77
FT                   /note="Required for enzyme activity"
FT                   /evidence="ECO:0000250|UniProtKB:Q6UWV6"
FT   ACT_SITE        74
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000250|UniProtKB:Q6UWV6"
FT   BINDING         38
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:Q6UWV6"
FT   BINDING         74
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:Q6UWV6"
FT   BINDING         95
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:Q6UWV6"
FT   BINDING         198
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:Q6UWV6"
FT   BINDING         202
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:Q6UWV6"
FT   BINDING         245
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:Q6UWV6"
FT   BINDING         246
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:Q6UWV6"
FT   BINDING         352
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:Q6UWV6"
FT   CARBOHYD        99
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        120
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        145
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        167
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        266
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   MUTAGEN         198
FT                   /note="D->A: Abolishes the phosphoric diester hydrolase
FT                   activity against PAF."
FT                   /evidence="ECO:0000269|PubMed:16255717"
FT   MUTAGEN         245
FT                   /note="D->A: Abolishes the phosphoric diester hydrolase
FT                   activity against PAF."
FT                   /evidence="ECO:0000269|PubMed:16255717"
SQ   SEQUENCE   439 AA;  49837 MW;  7CEABF0393C9480F CRC64;
     MGHSAVLLSV ALVILPACVT GGPVQRQQQH KLLLVSFDGF RWNYDQDVET PNLDSMAQEG
     VKARYMTPAF VTMTSPCHFT LVTGKYIENH GVVHNMFYNT TNKVRLPYHA TLGIQRWWDN
     GSIPIWITAQ RQGLKTGSFF YPGGNVTYQG EAVTMSRKEG VLHNYKNETE WRANVDTVMK
     WFTEEDVSLV TLYFGEPDST GHKYGPESQE RKDMVKQVDR TVGYLRDSIK RHHLTDSLNL
     IITSDHGMTT VNKKASDLVE FHKFPNFTFR DIEFELLDYG PNGMLIPKEG MLEKVYSVLK
     DAHPRLHVYK KEDFPKTFHY ANNPRITSLL MYSDLGYVIH GRVNVQFNSG EHGFDNQDMD
     MKTIFRAVGP SFKAGLEVEP FESVHVYELM CQLLGIVPEP NDGHPGVLQP MLRSGSPLSR
     QHHLVVVLMG ILTGLAKVV
//
